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The mesocorticolimbic dopamine system is essential
for cognitive and emotive brain functions and is thus
an important target in major brain diseases like
schizophrenia, drug addiction, and attention deficit
hyperactivity disorder. However, the cellular basis
for the diversity in behavioral functions and associ-
ated dopamine-release pattern within the mesocorti-
colimbic system has remained unclear. Here, we
report the identification of a type of dopaminergic
neuron within the mesocorticolimbic dopamine sys-
tem with unconventional fast-firing properties and
small DAT/TH mRNA expression ratios that selec-
tively projects to prefrontal cortex and nucleus
accumbens core and medial shell as well as to baso-
lateral amygdala. In contrast, well-described con-
ventional slow-firing dopamine midbrain neurons
only project to the lateral shell of the nucleus accum-
bens and the dorsolateral striatum. Among this dual
dopamine midbrain system defined in this study by
converging anatomical, electrophysiological, and
molecular properties, mesoprefrontal dopaminergic
neurons are unique, as only they do not possess
functional somatodendritic Girk2-coupled dopamine
D2 autoreceptors.
INTRODUCTION
The dopamine midbrain system is not only involved in motor
control and movement disorders like Parkinson disease, but
also plays a crucial part in many emotional and cognitive func-
tions of the brain and its major disturbances in schizophrenia,
drug addiction, and attention deficit hyperactivity disorder
(ADHD) (Bjorklund and Dunnett, 2007b). These latter functions
are mediated to a large degree by the mesocorticolimbic dopa-
mine system, which is comprised of dopaminergic (DA) midbrain
projections from the ventral tegmental area (VTA, A10) and the
neighboring substantia nigra (SN, A9) to cortical territories and
subcortical limbic areas including, prominently, the shell and760 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.the core regions of the nucleus accumbens (NAc) and the
basolateral amygdala (BLA) (Bjorklund and Dunnett, 2007a).
Given this degree of physiological and pathophysiological diver-
sity within the dopaminergic midbrain system, more selective
pharmacological targeting of its distinct projections is a highly
desired goal to prevent common side effects of conventional
treatments occurring in, for example, schizophrenia Fleisch-
hacker andWidschwendter, 2006) and Parkinson disease (Wein-
traub and Stern, 2005).
However, while the neuroanatomical connectivity of themeso-
corticolimbic DA system has been extensively studied in rodents
and primates (Bjorklund and Dunnett, 2007a; Haber, 2003), its
functional and molecular properties are less well defined. Even
at the level of the well-studied basic electrophysiological proper-
ties of DA midbrain neurons (Grace et al., 2007; Schultz, 2007),
the degree of functional diversity associated with distinct axonal
targets remains unresolved. Schultz and colleagues have
successfully defined the computational roles of tonic and phasic
discharge patterns of conventional DA midbrain neurons in
reward-prediction error and uncertainty signaling (Fiorillo et al.,
2003; Schultz, 2007; Tobler et al., 2005). However, the neuro-
physiological basis for the slower and more sustained pattern
ofDA release in, for example, cortical target areasduring different
behavioral contexts, more related to salience (Bassareo et al.,
2002; Berridge, 2007; Di Chiara and Bassareo, 2007), effort
(Salamone et al., 2007), or workingmemory and cognitive control
(Aalto et al., 2005; Phillips et al., 2004; Stefani and Moghaddam,
2006), is still elusive. The fact that sustainedpatternsof dopamine
release occur in particular target areas of dopaminergic midbrain
neurons like the prefrontal cortex (Stefani and Moghaddam,
2006) suggests that functional DA diversity occurs in an anatom-
ically ordered fashion. To study the combined anatomical,
functional, and molecular properties of the mesocorticolimbic
dopamine system in comparison to the mesostriatal dopamine
system in adult (3-month-old) C57Bl6 mice, we carried out
selective retrograde tracing experiments, combined with im-
munohistochemistry, electrophysiological recordings, and UV-
laser-microdissection-basedquantitativemRNA-expressionpro-
filing of individual DA neurons. Here, we show that the dopamine
midbrain system consists indeed of two distinct types of DAmid-
brain neurons with nonoverlapping axonal target areas and very
different molecular and functional properties. In addition to
the well-studied conventional dopaminergic midbrain neurons,
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neurons, with very low expression of the plasma membrane
dopamine transporter (DAT). Among these fast-firing DA neu-
rons, those projecting to the prefrontal cortex were unique, as
they possessed no functional somatodendritic dopamine D2
autoreceptors and expressed very lowmRNA levels of D2 dopa-
mine receptors and their downstream targets, the GIRK2
channel, at the level of individual neurons. Thus, we provide
here a cellular and molecular basis for the regional and temporal
diversity of dopamine signaling in the adult brain that might facil-
itate more selective therapeutic targeting of dopaminergic
subsystems, differentially affected in disorders like schizophre-
nia and Parkinson disease.
RESULTS
Anatomical Segregation of the Different Projections
of the Mesocorticolimbic Dopaminergic System
in the Midbrain Suggests a Dual System
First, we mapped the anatomical distribution of retrogradely
labeled and immunohistochemically identified TH-positive (TH+,
i.e., dopaminergic, DA) midbrain neurons for the five different
mesocorticolimbic target regions: medial prefrontal cortex
(mPFC), basolateral amygdala (BLA), nucleus accumbens
(NAc) core, NAc medial shell, and the NAc lateral shell. For com-
parison, we also mapped the distribution of conventional nigros-
triatal DA neurons projecting to the dorsolateral striatum (DS).
Figure 1A shows the injection sites in the main target areas of
the mesocorticolimbic DA system: mPFC, BLA, NAc core, and
NAc medial and lateral shell. For comparison, the lowest panel
shows a dorsolateral striatal injection site for labeling of the ni-
grostriatal DA system. While the left halves of the figures show
examples of the respective injection sites, the right halves dis-
play color-coded schematic overlays of the three to five different,
selective tracing experiments carried out for each of the meso-
corticolimbic target areas at the same caudorostral level. Impor-
tantly, Figure S1 (available online) documents the selectivity of all
injection sites used for the anatomical mapping of all six different
targets by their complete caudorostral serial reconstructions.
Figures 1B and 1C compare the cumulative anatomical distribu-
tion of retrogradely labeled and immunohistochemically identi-
fied TH-positive neurons for the six different target regions at
the same caudorostral levels in the posterior midbrain (bregma
3.49 mm; respective areas of three distinct subnuclei of the
VTA indicated by different colors). Our data show that DA neu-
rons projecting to mPFC, BLA, and NAc core and medial shell
cluster in the medial posterior VTA, where they were predomi-
nantly located both in the medial paranigral (PN) nucleus and
the adjacent medioventral aspects of the parabrachial (PBP)
nucleus, while only a smaller population of DA neurons with
these projections were found in the adjacent interfascicular (IF)
nucleus close to midline. In contrast, DA neurons projecting to
the lateral shell region of the NAc were almost completely ex-
cluded fromPNandwere scattered throughout the PBP. Outside
the VTA (A10), a significant portion of these NAc lateral shell pro-
jecting DA neurons was situated in the most medial aspects of
the substantia nigra (SN, A9) pars compacta. For comparison,
DA neurons projecting to the dorsolateral striatum were almostexclusively found in the SN. Complete serial reconstructions
throughout the entire caudorostral span of the midbrain were
carried out to define the positions of the TH+ DA neurons within
the VTA with the five distinct mesocorticolimbic target areas in
comparison with the mesostriatal projection (see Figure S2).
These data confirmed that only mPFC, BLA, and NAc core and
medial shell projecting DA neurons were located within the para-
nigral nucleus of the VTA, where almost no DA neurons projec-
ting to NAc lateral shell were found. As expected, mesostriatal
DA neurons were largely restricted to the SN, and none of
them were found in the PN. On the other hand, only mesostriatal
and mesolimbic lateral shell DA neurons were found in the retro-
rubral field (RRF, A8), while mesocortical, mesoamygdaloid, and
mesolimbic core and medial shell DA neurons were also located
in the rostral and central linear nuclei (RLi, CLi). Finally, the aver-
age cell diameters differed significantly between these two ana-
tomically segregated DA populations. DA neurons projecting to
mPFC, NAc core, NAc medial shell, and BLA were significantly
smaller compared to mesolimbic lateral shell and nigrostriatal
DA neurons (mesocortical, 17.5 ± 0.4 mm, n = 118;mesoamygda-
loid, 17.8 ± 0.7 mm, n = 48; mesolimbic core, 18.0 ± 0.5 mm,
n = 59; mesolimbic medial shell, 17.2 ± 0.5 mm, n = 45; mesolim-
bic lateral shell, *21.5 ± 0.5 mm, n = 59; mesostriatal, *24.0 ±
0.7 mm, n = 64, p < 0.001). In summary, we show a clear dual
anatomical and morphological segregation of the mesocortico-
limbic DA system. As shown in Figure S3, we also detected an
anatomical segregation between TH-positive and TH-negative
(i.e., nondopaminergic) midbrain neurons projecting to the
medial PFC. In contrast to mesoprefrontal DA neurons, which
clustered in and around the paranigral nucleus in the medial
posterior VTA, the PN was almost devoid of TH-negative meso-
cortical neurons, which instead were found in both more caudal
and rostral territories of the midbrain.
To study the independence of the distinct components of the
mesocorticolimbic DA projection system, we carried out double-
tracing experiments combining tracer injections of latex beads
with red fluorochromes to mPFC with green latex beads to either
the core or the lateral shell region of NAc. Respective injection
sites are shown in Figure 2A. Again, DA neurons were identified
by positive TH immunoreactivity (blue, Figure 2B). We found
mesocortical and mesolimbic core projecting DA neurons in
immediate proximity (Figure 2B, left panel), while mesocortical
and mesolimbic lateral shell DA neurons were significantly
more segregated and never direct neighbors (Figure 2B, right
panel, and Figure 2C). In addition, these double-labeling exper-
iments also showed that the vast majority of distinct mesocorti-
colimbic DA projections were organized as independent parallel
lines indicated by the only small percentage of single DA neurons
that harbored both green and red beads (12.5%, 4 of 32 meso-
cortical and mesolimbic core cells; 4.3%, 1 of 23 mesocortical
and mesolimbic lateral shell cells, Figure 2D).
Quantitative mRNA Expression Profiling
for the Different Projections of the Dopaminergic
Midbrain System Reveals the Dual Nature
of the Mesocorticolimbic Dopamine System
To address the question whether the five different parallel
projections of the mesocorticolimbic DA system, anatomicallyNeuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 761
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we quantified mRNA expression of important dopaminergic
marker genes, tyrosine hydroxylase (TH), the vesicular
monoamine transporter 2 (VMAT2), and the plasma membrane
dopamine transporter (DAT), which define dopamine synthesis,
packaging, and reuptake capacity of DA neurons, that project
to either mPFC, BLA, NAc core, or NAc medial or lateral shell.
Again for comparison, conventional nigrostriatal DA neurons
projecting to the dorsolateral striatum were also studied. As
shown for two of the six studied DA populations in Figures
3A–3C, after verified target-specific in vivo tracing, selective
pools of five bead-labeled neurons each were collected via
Figure 1. Topography and Anatomical Seg-
regation of Different Projections of theMes-
ocorticolimbic Midbrain System in Adult
Mice
(A) Injection sites for retrograde tracing experi-
ments using fluorescently labeled latex beads.
(Left panels) Injection sites in green nissl (488 nm)
counterstained 100 mm coronal sections from top
to bottom for mPFC (bregma +1.70 mm), BLA
(bregma 1.94 mm), NAc core (bregma +0.98
mm), NAc medial shell (bregma +1.34 mm), NAc
lateral shell (bregma +0.86 mm), DS (bregma
+1.10 mm). Arrows indicate the injected reservoir
of tracer beads. (Right panels) A schematic draw-
ing of the corresponding brain regions and outline
of the anatomical positions of the tracer depots.
The respective tracer areas of the individual
experiments in each target region (mPFC: n = 5,
BLA: n = 3, NAc core: n = 3, NAc medial shell:
n = 3, NAc lateral shell: n = 3, DS: n = 1) aremarked
with different colors. Scale bars, 500 mm.
(B) Anatomical positionsof retrogradely labeledDA
neurons in schematic drawings of the coronal
ventral midbrain including SN and VTA regions at
bregma 3.49 mm. Different subnuclei of the
VTA are color coded: paranigral (PN) = yellow,
parabrachial (PBP) = blue, interfascicularis (IF) =
green. Red dots represent the positions of individ-
ual tracer-bead-containing and TH-immunoposi-
tive neurons in VTA and SN accumulated from
one to five independent tracing experiments
shown in corresponding panels in (A).
(C) Relative distribution of retrogradely labeled DA
neurons between the three main VTA (A10) subnu-
clei PN, PBP, and IF. Note that a substantial
percentage of DA VTA neurons projecting to
mPFC (43.1%), BLA (28.1%), NAc core (33.4%),
and NAc medial shell (47.4%) are located in PN,
while mesolimbic lateral shell DA VTA neurons
(2.4%) and mesostriatal DA neurons (0%) are
almost or completely absent from PN.
UV-laser microdissection (LMD) from
coronal fixed cryosections for subse-
quent cDNA synthesis followed by quan-
titative real-time PCR (Liss et al., 2005).
Bead-labeled DA neurons with different
projections showed the same topogra-
phical distributions within the midbrain
as described above (Figures 3A and 3E; compare to Figure 1).
As shown in Figures 3D and 3E, the quantitative mRNA expres-
sion of TH, DAT, and VMAT2 were determined in parallel for each
pool of five DA neurons with defined axonal projections. In line
with our anatomical data, two significantly different patterns of
TH-DAT-VMAT2 coexpression were observed (compare Figures
3D and 3E), which are shown as relative DAT/TH and DAT/
VMAT2 expression ratios in Figures 3F and 3G, respectively.
Mesocorticolimbic DA neurons projecting to mPFC, BLA, or
NAc core or NAc medial shell displayed similarly low DAT/TH
expression ratios (relative DAT/TH ratios normalized to that of
mesocortical DA neurons: mesocortical 1.00 ± 0.12, n = 11;762 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.
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Unique Mesoprefrontal Dopamine Neuronsmesoamygdaloid 1.32 ± 0.41; n = 12; mesolimbic core 1.87 ±
0.33, n = 15; mesolimbic medial shell 1.27 ± 0.14, n = 20). In con-
trast, DAT/TH expression ratios of NAc lateral shell projecting DA
Figure 2. Double Tracing of the Mesocorticolimbic Dopaminergic
System Shows Independence and Spatial Organization of Its Dis-
tinct Projections
(A) Injection sites (arrows) in green nissl counterstained 100 mm sections of
double retrograde tracing experiments using red fluorescently labeled latex
beads for mPFC and green fluorescently labeled beads for injections into
NAc core (left panels) or NAc lateral shell (right panels). Sections at bregma
+1.34 mm (upper panels), +0.86 mm (lower panels). Scale bar, 500 mm.
(B) Confocal images of TH-immunopositive (blue) cells in the VTA labeled with
red beads for mesocortical neurons and with green beads for NAc core (left
panel) or NAc lateral shell (right panel) neurons, respectively. Arrows indicate
the distance between two labeled cells. Scale bars, 20 mm.
(C) Somata of mesolimbic core projecting DA neurons are significantly (p <
0.001) closer (83.9 ± 10.7 mm, n = 28 pairs, cumulative data from three inde-
pendent experiments) to identified mesocortical DA neurons than to those of
mesolimbic lateral shell DA neurons to mesocortical DA neurons (232.7 ±
24.3 mm, n = 26 pairs, cumulative data from three independent experiments).
Data are presented as means ± SEM.
(D) Cortical and subcortical projections of the mesocorticolimbic DA system
are largely independent parallel systems. Only 12.5% (n = 4 of 32 cells) or
4.3% (n = 1 of 23 cells) of mesocortical DA VTA neurons are double labeled af-
ter double tracing of mPFC and core or lateral shell of NAc, respectively. Insert
shows an example of a double-labeled DA neuron.neurons (3.61 ± 0.50, n = 16) and of mesostriatal DA SN neurons
(5.20 ± 0.22, n = 20; Figure 3F) were significantly higher. The
different DAT/TH ratios resulted mainly due to large differences
in DAT expression.
A similar pattern emerged when comparing the DAT/VMAT2
expression ratios. Again, mesocorticolimbic DA neurons
projecting to mPFC, BLA, or NAc core or medial shell shared
similar low DAT/VMAT2 expression ratios (DAT/VMAT2 ratios
normalized to mesocortical DA neurons: mesocortical 1.00 ±
0.19, n = 8; mesoamygdaloid 1.24 ± 0.25, n = 10; mesolimbic
core 1.51 ± 0.17, n = 13; mesolimbic medial shell 1.14 ± 0.13,
n = 19) compared to the significantly higher ratios of meso-
limbic lateral shell (2.95 ± 0.50, n = 15) and mesostriatal DA
neurons (2.81 ± 0.38, n = 20; Figure 3G). In essence, while
mesolimbic lateral shell VTA DA neurons shared the elevated
DAT/TH and DAT/VMAT2 mRNA expression ratios with the
mesostriatal DA SN neurons, all other constituents of the meso-
corticolimbic DA system formed—in line with their anatomical
segregation—a different group with significantly smaller DAT/
TH as well as DAT/VMAT2 mRNA expression ratios, caused
by lower DAT mRNA levels. These differences in relative
DAT expression were confirmed at the protein level by multi-
labeling immunohistochemistry and confocal analysis. As
shown in Figures 3H and 3I, somatodendritic DAT immunore-
activity of retrogradely identified mesocortical, TH-positive
neurons was in most cases not significantly different from
background (n = 12 of 16; 75%), compared to the strong
DAT immunoreactivity in retrogradely identified mesostriatal
DA SN neurons, which was found to be above background
in all analyzed neurons (n = 16 of 16; 100%). DA neurons pro-
jecting to BLA (n = 12 of 14; 87%), NAc core (n = 12 of 23;
52%), and NAc medial shell (n = 11 of 20; 55%) also showed
weak DAT immunoreactivity, while in contrast all analyzed
mesolimbic lateral shell projecting DA neurons possessed
strong DAT immunoreactivity (n = 12 of 12; 100%), similar to
mesostriatal DA SN neurons. Corresponding differences in
DAT immunoreactivities were also evident in the respective
axonal target areas (see Figure S4). A similar analysis of
calbindin d28k immunoreactivity showed that all DA neurons
projecting to mPFC (n = 38 of 38 cells), to BLA (n = 9 of 9
cells), to NAc core (n = 16 of 16 cells), and to NAc medial shell
(n = 8 of 8 cells) were calbindin immunopositive. However, so
were also 60% of DA neurons projecting to NAc lateral shell
(n = 12 of 20 cells) (see Figure S5A). Thus, in contrast to the
significant differences in DAT/TH and DAT/VMAT2 expression
ratios, calbindin d28k expression alone was not a fully reliable
marker to differentiate between the two distinct subtypes of
mesocorticolimbic DA neurons.
As shown in Figure S5B, mesocortical DA neurons not only
coexpressed TH, DAT, and VMAT2, but also, like conventional
nigrostriatal DA neurons, dopa decarboxylase (DDC), which
renders these unconventional TH-positive neurons fully compe-
tent not only to take up and package dopamine but also to
produce it enzymatically. However, their synthetic capacity for
catecholamines was restricted to dopamine, as they did not
coexpress TH and dopamine-b-hydroxylase (DBH) to produce
norepinephrine. (in contrast to mPFC-projecting locus coeruleus
neurons; compare Figures S5C and S5D).Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 763
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Is Composed of Two Distinct Functional Dopaminergic
Cell Types in a Projection-Specific Manner
To address the key question whether the anatomical and molec-
ular differences described above within the adult mesocortico-
limbic DA VTA system also extend into the electrophysiological
domain, we combined retrograde tracing with standard whole-
cell and perforated-patch patch-clamp recordings in in vitro
brain slices from 3-month-old adult C57Bl6 mice to study the
basic electrophysiological properties of these two distinct neuro-
nal dopaminergic subtypes. As in a previous study (Liss et al.,
2005), we confirmed the stereotypical and well-characterized
electrophysiological properties of nigrostriatal DA SN neurons
(Figures 4A and 4B). Figure 4B shows a single action potential
(AP) from a perforated-patch recording of a retrogradely identi-
fied mesostriatal SN DA neuron with its typical low threshold,
broad AP, and prominent afterhyperpolarization (AHP). For
detailed analysis of individual APs, only those perforated-patch
recordings with uncompensated series resistances <40 MU
were used. The second derivative of this action potential gives
rise to the well-known waveform (middle panel) that has been
utilized for cell identification in many in vivo extracellular studies
of DA midbrain neurons (Grace and Bunney, 1984b; Ungless
et al., 2004). The lower panel shows the phase plot of this AP.
In perforated-patch recordings, DA SN neurons discharge in
a slow regular pacemaker mode with typically broad action
potentials (2.3 ± 0.5 Hz, n = 20, range 1.2–3.2 Hz). Upon injection
of hyperpolarizing currents of increasing amplitudes, DA SN
neurons develop the typical and prominent HCN-channel-medi-
ated sag component in the subthreshold range (sag at 80 mV:
14.3 ± 1.0 mV, n = 4), which has routinely been used for func-
tional identification of dopaminergic midbrain neurons. In con-
trast, retrogradely identified mesocortical DA VTA neurons
possess highly distinct properties (Figures 4C and 4D). In perfo-
rated-patch recordings, their spontaneous discharge frequen-
cies were in most cases faster (5.6 ± 0.7 Hz, n = 20, range
1–12 Hz, p < 0.01) than those of conventional mesostriatal DA
neurons. Furthermore, upon injection of hyperpolarizing currents
of increasing amplitudes, mesocortical DA neurons demon-
strated no obvious sag components (sag at 80 mV: 2.9 ± 0.9
mV, n = 6), which corresponded to a lack of functional HCN
currents in voltage-clamp recordings (data not shown). With in-
creasing membrane hyperpolarizations, this DA subpopulation
showed instead a prominent rebound inhibition with a slow
return to the firing threshold (rebound delay: mesocortical 2.9 ±
0.7 s, n = 6; mesostriatal 0.5 ± 0.1 s, n = 4; p < 0.01). As shown
in Figure 4D, the durations of the APs in perforated-patch
recordings were even longer than those of conventional DA SN
neurons (AP duration at threshold: mesocortical 7.6 ± 1.4 ms,
n = 7; mesostriatal 3.5 ± 0.3 ms, n = 9; p < 0.01). Prominently,
they also lacked a clear afterhyperpolarization (AHP: mesocort-
ical 49.8 ± 3.1 mV, n = 9; mesostriatal 60.7 ± 1.2 mV, n = 14;
p < 0.01). Their phase plot also indicated significantly smaller
maximal depolarization (mesocortical: 24.4 ± 2.9 mVms1,
n = 5; mesostriatal: 86.5 ± 8.3 mVms1, n = 5; p < 0.01) and
repolarization speeds compared to those of mesostriatal DA
neurons (mesocortical:14.9 ± 4.9 mVms1, n = 5; mesostriatal:
51.6 ± 3.0 mVms1, n = 5; p < 0.01). Consequently, the second764 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.derivative of the AP waveform generated only a very small,
biphasic signal, which might be more difficult to detect in vivo
by extracellular recordings compared to that of mesostriatal
DA neurons.
To address the question whether these very different, ‘‘uncon-
ventional’’ functional phenotypes of mesocorticolimbic DA
neurons were associated in a systematic fashion with the distinct
anatomical and molecular subgroups defined above, we com-
bined retrograde tracing with standard whole-cell recordings,
neurobiotin filling, and immunohistochemistry, which allowed
electrophysiological analysis of retrogradely identified neurons
and unequivocal determination of the dopaminergic phenotype
for the same cell. In standard whole-cell recordings, uncompen-
sated series resistances were routinely <25 MU and allowed
analysis of fully resolved action potentials (e.g., mesocortical
DA neurons 15.1 ± 2.2 MU, n = 10). The data shown in Figures
5A–5C compare the AP discharge of retrogradely identified
TH+ neurons (Figure 5A) with defined axonal projections in
response to 2 s ramps of depolarizing currents at different ampli-
tudes to study the dynamic firing ranges of the respective DA
subtypes. In response to small current levels (Figure 5B, ramp
max +50 pA), DA neurons projecting to mPFC, BLA, NAc core,
and NAc medial shell discharged in a frequency range of
10–15 Hz (mPFC: 14.3 ± 1.1, n = 6; BLA: 11.8 ± 0.7, n = 9; NA
core: 11.8 ± 1.1, n = 8; NAc medial shell: 11.5 ± 1.4, n = 8), while
those DA neurons projecting to NAc lateral shell or to dorso-
lateral striatum fired action potentials in a significantly lower,
3–6 Hz frequency band (NAc lateral shell: 5.7 ± 0.5, n = 10; DS:
4.8 ± 0.2, n = 5, p < 0.001). In response to increasingly higher
ramp currents, all DA subtypes showed depolarization block
after reaching their maximal firing frequencies (Figure 5C). Again,
the DA neurons projecting to mPFC, BLA, NAc core, and NAc
medial shell showed significantly higher maximal discharge
frequencies in the range of 20–30 Hz (mPFC: 24.8 ± 2.9,
n = 13; BLA: 19.5 ± 1.1, n = 9; NAc core: 21.1 ± 2.3, n = 8; NAc
medial shell: 22.9 ± 2.7, n = 8), well above those DA neurons
that projected to NAc lateral shell and DS (NAc lateral shell: 9.0 ±
0.4, n = 28; DS: 9.5 ± 0.6, n = 13, p < 0.001, Figure 5D). The latter
remained in a frequency band below 10 Hz, consistent with the
well-described maximal tonic firing ranges of conventional DA
neurons in vivo and in vitro (Grace and Bunney, 1984b; Liss
et al., 2005). Moreover, the fast-firing DA phenotypes were
able to sustain higher firing ranges above the conventional upper
limit of 10 Hz for at least several seconds during ramp
depolarizations, in contrast to the conventional DA neurons
(Figure 5E) that might only reach higher firing-frequencies during
subsecond burst discharges in vitro and in vivo (Grace and
Bunney, 1984a; Wolfart and Roeper, 2002). Thus, adding to their
anatomical segregation and their quantitative molecular differ-
ences, the twoDA phenotypes identified here are able to operate
within two distinct frequency bands and temporal domains. A
variety of additional electrophysiological data for the six retro-
gradely identified DA subgroups (depicted in Figure S6) further
confirmed the clear functional distinctions between unconven-
tional VTA DA neurons projecting to mPFC, BLA, NAc core,
and medial shell compared to those projecting to NAc lateral
shell that possessed—like mesostriatal DA SN neurons—the
well-described classical DA phenotype. DA neurons projecting
Neuron
Unique Mesoprefrontal Dopamine NeuronsFigure 3. Quantitative RT-PCR of Retrogradely Labeled, Laser-Microdissected Neurons Indicates Two Molecularly Distinct Neuronal
Subtypes in the Mesocorticolimbic Dopamine System
(A and E) (Upper row) Anatomical positions of retrogradely labeled, UV-LMD collected DA neurons (as in Figure 1B), accumulated from one to four independent
tracing experiments (PFC: n = 3, BLA: n = 4, NAc core: n = 2, NAc medial shell: n = 2, NAc lateral shell: n = 2, DS: n = 2).
(B and C) Fluorescence (B) and bright-field DIC (C) images (LMD6000) of five bead-containing individual DA neurons with different projection sites, manually
marked under fluorescence illumination before (B) and after (C) UV-LMD. Scale bars, 25 mm.
(D and E) (Lower row) Semilogarithmic real-time PCR amplification plots for DAT (blue square), TH (green triangle), and VMAT2 (red diamond) using cDNA from
labeled cell pools (compare [B] and [C]) as templates. Grey lines indicate Ct-line of analysis. Note the earlier detection (= lower Ct value) of DAT in cells projecting
to the DS and NAc lateral shell compared to those projecting to NAc core, NAc medial shell, BLA, or PFC.Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 765
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similar AP waveforms (Figure S6A) that were significantly lon-
ger (mPFC: 6.7 ± 0.6 ms, n = 15; BLA: 6.5 ± 0.7 ms, n = 9;
NAc core: 4.4 ± 0.2 ms, n = 7; NAc medial shell: 4.5 ±
0.4 ms, n = 6; Figure S6B) and had much smaller AHPs
(mPFC: 47.7 ± 1.6 mV, n = 15, BLA: 39.0 ± 1.8 mV,
n = 9; NAc core: 41.2 ± 1.2 mV, n = 7; NAc medial shell:
41.7 ± 2.1 mV, n = 6; Figure S6C) compared to DA neurons
projecting to NAc lateral shell and DS (AP duration at thresh-
old: NAc lateral shell 3.2 ± 0.1 ms, n = 12; DS 3.1 ± 0.2 ms,
n = 13; AHP: NAc lateral shell 56.9 ± 1.8 mV, n = 12; DS
57.4 ± 1.2 mV, n = 10). In addition, all unconventional DA
neurons of the mesocorticolimbic system showed little to no
sag components followed by long rebound inhibitions in
response to hyperpolarizing currents (sag 80 mV: mPFC
3.8 ± 0.5 mV, n = 12; BLA 3.4 ± 0.6 mV, n = 9; NAc core
6.2 ± 1.5 mV, n = 13; NAc medial shell 4.1 ± 1.0 mV, n = 8;
rebound delay: mPFC 2.2 ± 0.5 s, n = 12; BLA 3.0 ± 0.5 s,
n = 7; NAc core 2.8 ± 0.5 s, n = 13; NAc medial shell 2.5 ±
0.5 s, n = 8). This subthreshold behavior was very different
compared to conventional mesolimbic lateral shell and
mesostriatal DA neurons (sag 80 mV: NAc lateral shell 14.4 ±
1.0, n = 36; DS 19.0 ± 0.8, n = 15; rebound delay: NAc lateral
shell 0.9 ± 0.2, n = 16; DS 0.4 ± 0.1, n = 11, Figures S6A,
S6D, and S6E).
In order to test the emerging dual nature of the dopaminergic
midbrain system and the existence of a second type of mesocor-
ticolimbic DA midbrain neuron in an unbiased manner, we
carried out an unsupervised hierarchical cluster analysis based
on a set of seven electrophysiological properties for 44 individual
DA midbrain neurons (pF, AP threshold [mV], AP duration [ms],
AHP [mV], max. firing rate [Hz], min. and max. speed of voltage
change during AP [mV/ms]). As shown in Figure S7, this analysis
indeed revealed two highly distinct (Wilk’s l = 0.170, p < 0.001)
groups of DA neurons, which for almost all cells (n = 41 of 44)
were in accordance with two distinct groups of DA neurons
based on their differences in axonal projections and gene
expression described above. A discrimination analysis revealed
that the AHP amplitude was the single most reliable functional
property to functionally discriminate the two distinct types of
DA neurons. The more subtle separation into several subgroups
within the two robust DA clusters showed smaller differences
between mesolimbic lateral shell and mesostriatal DA neurons,
as previously described (Liss et al., 2005), but linked no sub-
groups exclusively to their respective axonal projection area.
These clustering data independently confirmed the existence
of two highly distinct subtypes of dopaminergic midbrain neu-
rons, with nonoverlapping axonal targets and associated sys-
tematic differences in gene expression.766 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.Figure 4. The Dopaminergic Midbrain System Is Composed of Two
Highly Distinct Functional Phenotypes
(A) Gramicidin-perforated-patch recordings of an identified mesostriatal DA
neuron from 3-month-old mouse in current-clamp mode. Note slow regular
discharge with pronounced afterhyperpolarizations (AHPs) and sag compo-
nents induced by injections of hyperpolarizing currents of increasing
amplitudes (steps of 25 pA).
(B) Gramicidin-perforated-patch recordings of an identified mesostriatal DA
neuron from 3-month-old mouse in current-clamp mode. Note typical action
potential (AP) waveform (upper panel). Second derivative of the AP is shown
in middle panel. Lower panel shows the phase plot (mVms1/mV) of the AP.
(C) Gramicidin-perforated-patch recordings of an identified mesocortical DA
neuron from 3-month-old mouse in current-clamp mode. Note fast regular
discharge and absence of AHPs and sag components. Injections of hyperpo-
larizing currents as in (A).
(D) Gramicidin-perforated-patch recordings of an identified mesocortical DA
neuron from 3-month-old mouse in current-clamp mode. Note broad AP
waveform without AHP (upper panel). Second derivative of the AP is shown
in middle panel. Note the small amplitude in comparison to (B). Lower panel
shows the phase plot (mVms1/mV) of the APwith smallermaximal depolariza-
tion and repolarization speeds.(F and G) Statistical analysis of real-time PCR experiments. DA neurons projecting to NAc core, NAc medial shell, BLA, and PFC show significantly lower DAT/TH
expression ratios as well as lower DAT/VMAT2 expression ratios relative to neurons projecting to NAc lateral shell or DS (ratios normalized; PFC = 1). Data are
presented as means ± SEM.
(H) Confocal images of DAT immunoreactivity (white) of TH-immunopositive (green) cells labeled with red beads for mesocortical DA neurons (left panel) or
mesostriatal DA neurons (right panel). Scale bar, 20 mm.
(I) Only 25% (n = 4 of 16 cells) of mesocortical DA neurons, 14% (n = 2 of 14 cells) of mesoamygdaloid DA neurons, 48% (n = 11 of 23 cells) of mesolimbic core DA,
and 45% (n = 9 of 20 cells) of mesolimbic medial shell DA neurons showed DAT immunoreactivity above background. In contrast, DAT immunoreactivity was
significantly different from background in all analyzed mesolimbic lateral shell (n = 12 of 12 cells) and mesostriatal DA neurons (n = 16 of 16 cells).
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gated Functional Phenotypes of the Dopa-
minergic Midbrain System Operate in
Different Frequency Bands
(A) Confocal analysis of individual retrogradely
labeled (red beads), recorded, neurobiotin-filled
(green), and TH-immunopositive (blue) neurons.
(B and C) Whole-cell, current-clamp responses to
2 s ramps of small depolarizing currents (+50 pA)
of the retrogradely identified DA neurons. Note
that mesocortical, mesoamygdaloid, mesolimbic
core, and mesolimbic medial shell DA neurons
discharge even in response to small current injec-
tions in a higher frequency range compared to
mesolimbic lateral shell and mesostriatal DA neu-
rons. (C) During 2 s ramp current injections of
larger amplitudes (100–200 pA), all DA subtypes
showed depolarization block of spontaneous
electrical activity after discharging at different
maximal frequencies (scale bars: 20 mV, 500
ms). Note reduction of AP amplitudes in fast-firing
DA neurons before onset of depolarization block.
(D) Mean maximal firing rates of retrogradely
identified DA neurons induced by ramp depolar-
izations. Mesocortical (24.8 ± 2.9 Hz, n = 13), mes-
oamygdaloid (19.5 ± 1.1 Hz, n = 9), mesolimbic
core (21.1 ± 2.3 Hz, n = 8), and mesolimbic medial
shell (22.9 ± 2.7 Hz, n = 8) DA neurons showed sig-
nificantly higher maximal discharge rates com-
pared to mesolimbic lateral shell (9.0 ± 0.4 Hz,
n = 28) and mesostriatal (9.5 ± 0.6 Hz, n = 13) DA
neurons (p < 0.001). Data are presented as means
± SEM.
(E) Mesocortical (brown, n = 6), mesoamygdaloid
(black, n = 9), mesolimbic core (blue, n = 8), and
mesolimbic medial shell (gray, n = 8) DA neurons
are able to sustain higher firing ranges above the
conventional upper limit of 10 Hz (dashed horizon-
tal line) for several seconds during 2 s ramp depo-
larization of small depolarizing currents (+50 pA,
+100 pA, + 150 pA). In contrast, mesolimbic lateral
shell (green, n = 10) and mesostriatal (red, n = 5)
DA neurons could only maintain rates below this
limit for several seconds. (The dashed vertical
line at 270 ms indicates the average duration of
phasic high-frequency bursting in conventional
midbrain DA neurons.) Data are presented as
means ± SEM.Mesoprefrontal Dopamine Neurons Are Unique
within the Dual DA Midbrain System Due to Their Lack
of Functional Somatodendritic D2 Autoreceptors
Another criterion—with important therapeutic implications—that
has been widely used to define DA midbrain neurons is the inhi-
bition of their electrical activity by stimulation of somatodendritic
D2-type dopamine autoreceptors, which in turn activate G
protein-coupled potassium channels (e.g., GIRK2, Kir3.2) and
thereby hyperpolarize the plasma membrane (Beckstead et al.,
2004). We carried out perforated-patch-clamp recordings to
monitor effects of dopamine on spontaneous electrical activity
of retrogradely identified DA neurons from all six anatomically
defined groups. For maximal stimulation of both synaptic andextrasynaptic D2 autoreceptors on the somatodendritic mem-
brane (Beckstead and Williams, 2007), we bath applied 100 mM
dopamine, which led to membrane hyperpolarization (61.7 ±
4.7 mV, n = 7) accompanied by a complete and stable cessation
of spontaneous electrical activity (7 of 7 cells, Figure 6C) in all
tested mesostriatal DA SN neurons. Very similar to mesostriatal
DA neurons, electrical activity was completely suppressed
throughout the dopamine bath application in all mesolimbic DA
VTA neurons projecting to the lateral shell region of the NAc
(63.8 ± 1.0 mV, n = 7, Figure 6B) and only slowly returned after
the washout of dopamine. Similar, pacemaker activities of mes-
oamygdaloid DA VTA neurons (59.1 ± 3.5mV, n = 3, Figure 6C),
mesolimbic core DA neurons (62.8 ± 7.3 mV, n = 5, Figure 6C),Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 767
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Figure 6C) were also completely suppressed by 100 mM dopa-
mine. However, in contrast to all other DA VTA neurons of the
mesocorticolimbic system, only those projecting to mPFC did
not respond to dopamine application in all tested cells (n = 7,
Figure 6A). These differences in D2 autoreceptor signaling dem-
onstrate that mesocortical DA neurons possess unique proper-
ties within the framework of a dual DA midbrain system. The ab-
sence of D2 receptor-mediated inhibition of mesocortical DA
neurons was selective for dopamine and not due to a general fail-
Figure 6. Mesoprefrontal Dopamine Neurons Are Unique Due to
Their Absence of Functional Somatodendritic D2 Autoreceptors
(A and B) Gramicidin-perforated-patch recordings of identified mesocortical
DA neuron (A) and mesolimbic lateral shell DA neuron (B). Left panels show
electrical activity in control (upper), in the presence of 100 mM dopamine (mid-
dle), and after washout of dopamine (lower). Right panels plot the normalized
mean spontaneous discharge frequencies before, during, and after dopamine
application for identified mesocortical DA neurons (n = 7) and mesolimbic lat-
eral shell DA neurons (n = 7). Note the complete absence of dopamine-medi-
ated inhibition in mesocortical DA neurons and the complete and sustained
inhibition of mesolimbic lateral shell DA neurons by dopamine. Data are pre-
sented as means ± SEM.
(C) Normalized mean spontaneous discharge frequencies of identified meso-
amygdaloid DA neurons (n = 3), mesolimbic core (n = 5), mesolimbic medial
shell (n = 3), and mesostriatal (n = 7) DA neurons before, during, and after ap-
plication of 100 mMdopamine. Note that complete inhibition of electrical activ-
ity was not fully sustained inmesoamygdaloid, mesolimbic core, andmesolim-
bic medial shell DA subtypes. Data are presented as means ± SEM.768 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.ure of inhibition by neurotransmitter application. As shown in
Figure S8, similar to nigrostriatal DA neurons, mesocortical DA
neurons were readily hyperpolarized and electrically silenced
by bath application of either 1 mMGABA (mesocortical:62.7 ±
4.7, n = 3; nigrostriatal: 76.8 ± 2.5 mV, n = 4) or 10 mM baclo-
fen (mesocortical: 66.2 ± 8.5, n = 3; nigrostriatal: 84.1 ±
1.2 mV, n = 4).
Low Expression Levels of D2 Dopamine Receptor
and GIRK2 Channel mRNAs in Single Mesocortical
DA Neurons
To study the molecular nature of this observed difference in
somatodendritic D2 autoreceptor responses between meso-
cortical DA neurons and all other DA midbrain populations, we
again turned to cell-specific UV-laser microdissection of retro-
gradely identified DA neurons. Via RT-qPCR, we quantified
mRNA of D2 receptors and GIRK2 channels in single neurons
with defined axonal projections. To minimize the effects of
interindividual differences, we carried out double tracings of
mesocortical and mesostriatal DA neurons. Figure 7A shows
examples of differently labeled mesocortical and mesostriatal
DA neurons within the same animal before UV-laser microdis-
section of individual traced neurons, while Figure 7B plots rela-
tive positions of all analyzed neurons within the ventral midbrain
(compare Figure 1). The single-cell cDNA of each individual DA
neuron was purified and split for quantitative PCR of D2 and
GIRK2. Figures 7C–7E show that individual mesostriatal DA
neurons possessed at least one order of magnitude higher
mRNA levels of both GIRK2 and D2 compared to those of
mesocortical DA neurons (GIRK2, 10.0-fold: 3.84 ± 0.93,
n = 11 of 20mesocortical; 38.48 ± 0.24, n = 25 of 30mesostriatal.
D2, 14.7-fold: 2.60 ± 0.80, n = 8 of 20mesocortical; 38.28 ± 0.27,
n = 26 of 30 mesostriatal). As we analyzed the expression of
GIRK2 and D2 in parallel in single mesocortical or mesostriatal
DA neurons, we could also determine the single-cell expression
ratios of these two genes for individual neurons. While GIRK2
and D2 mRNA were codetected in most (80%, n = 24 of 30) of
the tested single mesostriatal DA neurons, only in 25% (n = 5
of 20) of mesocortical DA neurons were both transcripts
detected. In contrast to the significant differences in mRNA
abundances for both GIRK2 and D2 between the two different
types of dopaminergic neurons, their respective expression
ratios were very similar (mesostriatal: 0.84 ± 0.11, n = 24; meso-
cortical: 0.76 ± 0.31, n = 5, Figure 7G), indicating that these
genes were tightly coregulated across different DA subtypes.
We finally wished to study also the differences of GIRK2 and
D2 protein expression between these two types of dopaminergic
neurons. Unfortunately, none of the four different D2 antibodies
tested showed specific immunostaining when compared to
corresponding sections of a D2 knockout mouse (see Experi-
mental Procedures)—forcing us to restrict our analysis to
GIRK2 immunoreactivity. As shown in Figure 8, we carried out
a semiquantitative analysis of GIRK2 immunoreactivities for
retrogradely identified mesocortical and mesostriatal DA
subpopulations (see Experimental Procedures and Supplemen-
tal Data for details). While the GIRK2 immunosignals of meso-
cortical DA neurons were close to background (cell/background
ratio mPFC: 1.5 ± 0.1, n = 10), consistent with the low mRNA
Neuron
Unique Mesoprefrontal Dopamine Neuronsabundance of GIRK2 and the absent D2/GIRK2-mediated inhibi-
tion of these DA neurons, the GIRK2 immunosignals of meso-
striatal DA SN neurons were almost 5-fold larger compared to
background (DS: 4.6 ± 0.5, n = 10, Figure 8C).
DISCUSSION
Our study demonstrates that the adult dopaminergic midbrain
system is composed of two different, functionally and molecu-
larly distinct types of dopaminergic neurons with anatomical
segregation in the midbrain and nonoverlapping axonal targets.
Among this dual system, DA neurons projecting to medial
Figure 7. Quantitative Single-Cell RT-PCR
Reveals Lower Abundance of GIRK2 and
D2 mRNA in Mesocortical Compared to
Mesostriatal Dopaminergic Neurons
(A) LMD6000 images of bead-containing individual
DA neurons (indicated by arrow), projecting to
mPFC (left, red beads) or DS (right, green beads)
of a double-traced animal before UV-laser micro-
dissection. Scale bars, 25 mm.
(B) Relative anatomical positions of retrogradely
labeled individual mesocortical (red dots) and
mesostriatal (green dots) DA neurons collected
via UV-LMD (three independent tracing experi-
ments).
(C and E) Real-time PCR amplification plots of
GIRK2 (upper) and D2 (lower) of individual retro-
gradely identified neurons, one projecting to
mPFC (gray squares), the other to dorsolateral
striatum (black squares). Inserts show semiloga-
rithmic amplification plots. Red lines indicate
Ct-lines for analysis. Note the detection (Ct-value)
of GIRK2 and D2 at lower PCR cycles in the meso-
striatal compared to the mesocortical DA neuron.
(D and F) Calculated number of GIRK2 (upper) and
D2 (lower) mRNAmolecules are significantly lower
in mesocortical DA neurons (gray bars: GIRK2:
3.84 ± 0.93, n = 11 of 20; D2: 2.60 ± 0.80, n = 8 of
20) compared to mesostriatal DA neurons (black
bars: GIRK2: 38.48 ± 0.24, n = 25 of 30; D2:
38.28 ± 0.27, n = 26 of 30). Data are presented as
means ± SEM.
(G) Single-cell D2/GIRK2 mRNA expression ratios
of mesocortical (0.76 ± 0.31, n = 5 of 20) and mes-
ostriatal (0.84 ± 0.11, n = 24 of 30) DA neurons are
not significantly different. Data are presented as
means ± SEM.
prefrontal cortex are unique due to their
absence of functional somatodendritic
D2 receptors. Our findings help to resolve
a debate about the degree of cellular
diversity within the dopaminergic mid-
brain system (Chiodo et al., 1984; Deniau
et al., 1980; Gariano et al., 1989; Shepard
and German, 1984). Chiodo and col-
leagues (Chiodo et al., 1984) presented
evidence that DA neurons projecting to
cortical areas possessed distinct in vivo
properties compared to ‘‘conventional’’
nigrostriatal DAneurons,which either discharged in apacemaker
mode below 10 Hz or in short bursts at higher frequencies (Grace
et al., 2007). These functional differences included higher pace-
maker frequencies and the apparent lack of inhibition by soma-
todendritic D2 autoreceptors, another hallmark of conventional
DA midbrain neurons (Beckstead et al., 2004). However, other
groups did not find evidence for these fast-firing, atypical meso-
cortical DA neurons (Deniau et al., 1980; Gariano et al., 1989;
Shepard and German, 1984). More recent in vitro brain slice
studies of DA midbrain neurons (Ford et al., 2006; Liss et al.,
2005; Margolis et al., 2006a) accumulated further evidence that
DA midbrain neurons differed in certain electrophysiologicalNeuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 769
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2002; Wolfart et al., 2001). However, a general scheme combin-
ing the levels of recognized anatomical, functional, and molecu-
lar diversity of the adult DA midbrain system did not emerge
(Bjorklund and Dunnett, 2007a, 2007b). Such a scheme is
essential to define the cellular basis for the temporal and regional
variety of behaviorally relevant dopamine signaling in the brain
(Schultz, 2007).
We show here that mesocorticolimbic DA midbrain neurons
projecting selectively to medial prefrontal cortex, basolateral
amygdala, and the core and the medial shell of nucleus accum-
bens are able to fire action potentials at significantly higher
frequencies in a sustained fashion compared to the ‘‘conven-
tional’’ DA neurons (<10Hz). Among these fast-firingDAneurons,
only mesocortical DA neurons were not inhibited by somatoden-
dritic D2 receptor activation. The ability of these DA subtypes to
fire at higher frequencies in a sustained fashion is a candidate
mechanism that could contribute to the more sustained DA
release pattern in vivo recognized in particular in the amygdala
and the prefrontal cortex (Garris and Wightman, 1994; Mundorf
et al., 2001). In the case of the mesocortical DA neurons, the
lack of somatodendritic dopamine inhibition would further
facilitate sustained electrical discharge and release. The linear
Figure 8. Differences in GIRK2 Immunore-
activities between Mesocortical and Meso-
striatal DA Neurons
(A) Confocal images of GIRK2 immunoreactivity
(white) of TH-immunopositive (green) cells labeled
with red beads for mesocortical DA neurons (left
panel) or mesostriatal DA neurons (right panel).
Overlays are shown in lower right panels. Scale
bars, 20 mm.
(B) Frequency distributions of nuclear GIRK2
background signal (blue) and the cellular GIRK2
signal (red) for the mesocortical and mesostriatal
DA neurons shown in (A). Insets indicate region
of interests (ROI) for GIRK2 cellular and nuclear
background signal.
(C) Mean cellular GIRK2 immunosignals for re-
trogradely identified mesocortical (50.2 ± 3.3,
n = 10) andmesostriatal DA neurons (mesostriatal:
99.2 ± 5.9, n = 10, p < 0.001, left panel). GIRK2
background signals were not significantly different
(mesocortical: 33.6 ± 3.0, n = 10; mesostriatal:
25.3 ± 3.9, n = 10, p > 0.05, middle panel). Signifi-
cantly higher GIRK2 cell/background ratios for
mesostriatal (4.6 ± 0.5, n = 10, p < 0.001)
compared to mesocortical DA neurons (1.5 ± 0.1,
n = 10, right panel). Data are presented as means
± SEM.
increase in prefrontal dopamine overflow
in vivo in response to medial forebrain
bundle stimulations in a range between
20and60Hz (Yavich et al., 2007) supports
our notion that sustained fast firing of
mesocorticolimbic DA neurons could
shape the temporal pattern of dopamine
in its axonal target areas.
Once dopamine is released, DAT-
mediated reuptake is one of the key
mechanisms that defines decay kinetics of extracellular dopa-
mine concentrations. We show here that mesocortical DA
neurons possess the lowest DAT mRNA expression compared
to all other DA subtypes. Also, DAT/TH and DAT/VMAT2
mRNA expression ratios were lowest in mesocortical DA
neurons. Thus, a small dopamine reuptake capacity relative to
TH-mediated synthesis and VMAT2-mediated vesicular packag-
ing of dopamine is expected to contribute to the 10-fold slower
decay of extracellular dopamine concentrations in cortical areas
compared to those in dorsal striatum (Yavich et al., 2007). Thus,
based on the combination of our functional and molecular data,
the fast-firing mesocorticolimbic DA neurons with a low dopa-
mine reuptake capacity appear well suited to mediate the often
sustained forms of behaviorally relevant DA release in vivo in
several brain regions (Bassareo et al., 2002; Floresco et al.,
2003; Schultz, 2007; Stefani and Moghaddam, 2006) (notwith-
standing the ongoing technical debate of temporal resolution
and specificity of DA detection in vivo [Wightman, 2006]). Given
these considerations, atypical DA midbrain neurons might be
specifically involved in, for example, working memory (Phillips
et al., 2004; Seamans and Yang, 2004; Stefani andMoghaddam,
2006), fear conditioning (Marowsky et al., 2005; Rosenkranz and
Grace, 2002), or drug addiction (Cardinal et al., 2001; Dalley770 Neuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc.
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DA neurons projecting to either prefrontal cortex or medial shell
of the nucleus accumbens, which share the fast-firing electro-
physiological phenotype and possess very similar DAT/TH and
DAT/VMAT2 expression ratios, are known to give rise to very
different patterns of DA release in vivo might serve as a reminder
that additional factors, such as size and density of the axonal
terminal regions, presynaptic regulation, and plasticity, etc.,
also shape the temporal profile of extracellular dopamine
(Schmitz et al., 2003). In addition, insights into differences in
synaptic connectivity (Carr et al., 1999; Carr and Sesack, 2000)
and plasticity (Martin et al., 2006; Ungless et al., 2003) between
DA subtypes are equally important for our understanding of their
various behavioral roles in vivo. Future studies using in vivo
recordings of these unconventional DA neurons will be critical
to further define their distinct functional roles and the relation
between their electrical activity and dopamine release.
The uniquely absent D2 autoreceptor-mediated inhibition of
electrical activity of mesocortical DA neurons could play an
important role in the context of thewell-known differential effects
of antipsychotics. This might be further exploited for more selec-
tive targeting of the dopaminergic subsystems. This study
provides a set of available molecular markers (DAT, TH,
VMAT2, D2, GIRK2—but not calbindin d28k) that will reliably
allow the identification and discrimination of the dopaminergic
subtypes. In contrast, we foundno clear evidence for a coexpres-
sion of dopaminergic with glutamatergic marker genes in the
mesocorticolimbic system, which has been discussed as a
potentially differential marker by previous studies (Lavin et al.,
2005), but rather an anatomical segregation of ascending dopa-
minergic and nondopaminergic midbrain systems. Although our
analysis of the DA midbrain system was restricted to the adult
mouse brain, where anatomical, functional, and molecular
approaches can be combined, our findings will also facilitate
the analysis of diversity in the largely expanded DA midbrain
system of primates and humans (Haber, 2003), where distinct
DA subtypes regarding DAT and D2 abundance have already
been described (Haber et al., 1995; Lewis et al., 2001). The
established combination of single-cell UV-laser microdissection
and quantitative mRNA expression profiling for human DA
midbrain neurons from post mortem brains (Ramirez et al.,
2006) will allow probing of the human DA midbrain system. In
analogy to our findings in mouse brain, mesocortical DA neurons
might be identified by their low D2 and GIRK2 expression levels
combined with their low DAT/TH and DAT/VMAT2 mRNA ratios
and in addition by their expected low mRNA abundances for
SK3 (Wolfart et al., 2001) and HCN channel subunits (Neuhoff
et al., 2002).
Taken together, the anatomical, molecular, and functional
identification of a subtype of mesocorticolimbic dopaminergic
midbrain neuron, and its specific projections to medial prefrontal
cortex, basolateral amygdala, and nucleus accumbens core and
medial shell, offer rational cellular andmolecular targets for more
selective therapeutic interventions into the dopaminergic
midbrain system, in particular, for specific pharmacological
modulation of electrical activity and dopamine release of the
mesocorticolimbic DA system, for example, in diseases like
schizophrenia (Winterer and Weinberger, 2004), drug abuse(Everitt and Robbins, 2005), and ADHD (Arnsten, 2006), where
either altered cortical or limbic dopamine signaling are key
features of the pathophysiology. The desired subtype-specific
pharmacological modulation (either stimulation or inhibition) of
the distinct dopaminergic midbrain projections also holds the
long-term promise of reducing the high prevalence of severe
side effects in current treatments of major diseases like schizo-
phrenia (Fleischhacker and Widschwendter, 2006) and Parkin-
son’s disease (Weintraub and Stern, 2005).
EXPERIMENTAL PROCEDURES
Retrograde Tracing
Essentially as already described (Liss et al., 2005). In all experiments, male
adult (3-month-old) C57Bl6 mice were used, and all procedures were
approved by the German Regierungspra¨sidium Giessen and Darmstadt. For
a detailed description, see Supplemental Data. Briefly, under general
ketamine-dormitor anesthesia and stereotactic control (Cartesian Instru-
ments), retrobeads (Lumafluor, Naples, F) were injected unilaterally in dorso-
lateral striatum (DS) (bregma: 0.98 mm, lateral: 1.9 mm, ventral: 2.2 mm; 80
nl beads), nucleus accumbens (NAc) lateral shell (bregma: 1.45 mm, lateral:
1.75 mm, ventral: 4.0 mm; 80 nl beads), NAc medial shell (bregma: 1.78 mm,
lateral: 0.4 mm, ventral: 4.1 mm; 80 nl beads), NAc core (bregma: 1.54 mm,
lateral: 1.0 mm, ventral: 4.0 mm; 80 nl beads), basolateral amygdala (BLA)
(bregma:1.54 mm, lateral: 2.8 mm, ventral: 4.3 mm; 100 nl beads), or medial
prefrontal cortex (mPFC) (quadruple injection of each 100 nl beads at four
different sites: bregma: 1.95 mm, 2.05 mm, 2.15 mm, and 2.25 mm, lateral:
0.27 mm, ventral: 2.1 mm+ 1.6mm). We noticed that these empirically derived
stereotaxic coordinates did not match those given in the mouse brain atlas by
Franklin and Paxinos (2001), which we used as reference for our serial recon-
structions (on average the caudal-rostral axis appeared to be ca. 400 mm
shifted caudally). For sufficient labeling, survival periods for retrograde tracer
transport depended on respective injection areas: DS and NAc lateral shell,
7 days; NAc core, NAc medial shell, and BLA, 14 days; and mPFC, 21 days.
Electrophysiological Recordings from Adult Mouse Brain Slices
Essentially as previously described (Liss et al., 2005; Neuhoff et al., 2002). For
detailed description, see Supplemental Data.
Immunohistochemistry and Semiquantitative Analysis
of GIRK2 Immunostaining
Immunohistochemistry and confocal microscopy were as previously
described (Neuhoff et al., 2002; Wolfart et al., 2001). For a detailed description,
see Supplemental Data.
Brain Mapping
TH-stained coronal midbrain sections (50 mm) were reconstructed with
Neurolucida Software (MicroBrightfield, Colchester, VT) by using a LUDL
motor-driven microscope stage (LUDL Electronic Products, Hawthorne, NY)
and the Lucivid camera system (MicroBrightfield). TH-positive and labeled
cells were mapped and counted by scanning the midbrain sections with
a 633/1.25 oil lens. Sections were located relative to Bregma by using land-
marks and neuroanatomical nomenclature as described in the Franklin and
Paxinos mouse brain atlas (Franklin and Paxinos, 2001).
UV-Laser Microdissection
Laser microdissection (LMD) was performed essentially as already described
(Liss et al., 2005), using an LMD6000 system (Leica Microsystems). Coronal
cryosections (12 mm) of mouse midbrains were cut (Leica cryostat CM1850),
mounted on RNase-free UV-light-treated membrane slides (1 mm polyethyl-
ene-naphthalate membrane, MicroDissect), fixed with ethanol (75% [20C],
75%, 95%, 100%, 100% [RT each]), and air dried. Retrobead-labeled neurons
were visualized (633 objective) and marked under fluorescence illumination
(red beads: N2.1 filter, 515–560 nm excitation; green beads: L5 filter, 480 ±
40 nm excitation). Fluorescence-labeled neurons were cut under bright-fieldNeuron 57, 760–773, March 13, 2008 ª2008 Elsevier Inc. 771
Neuron
Unique Mesoprefrontal Dopamine NeuronsDIC microscopy and collected by gravity directly into a cap of a 0.5 ml thin-
walled PCR-tube (Applied Biosystems). The mixture for cell lysis and cDNA
synthesis was added directly into the lid, and reverse transcription was
performed as described (Liss et al., 2005; Ramirez et al., 2006).
Quantitative Real-Time PCR (TaqMan Primer/Probes)
Purification of cDNA and quantitative real-time PCR were essentially as previ-
ously described (Liss et al., 2001, 2005). cDNA pellet was dissolved in appro-
priate volumes of molecular biology grade water (5 ml per assay) for 1–2 hr at
45C. One-half of purified single-cell cDNA (for simultaneous D2 and GIRK2
quantification), or one-third of cell-pool cDNA (for simultaneous TH, DAT,
and VMAT2 detection) each was used as templates in 20 ml PCR reactions
with QuantiTect Probe PCR Master Mix (QIAGEN, no UNG, ROX as passive
reference dye). Real-time TaqMan assays were either obtained from Applied
Biosystems (D2, GIRK2) or from Metabion (TH, DAT, VMAT2). For a more
detailed description, see Supplemental Data.
Statistics
Student’s t tests or one-way ANOVA tests were used to determine statistical
differences using GraphPad prism 5 (Graphpad Software, San Diego, CA).
Bonferroni post hoc analysis was applied, when necessary, to compare
means. Statistical significance was set at p < 0.05. All data values are
presented as means ± SEM.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/5/760/DC1/.
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